Key result
GLS tracks progressive cardiac amyloidosis, worsening by ~8 percentage points over 6 months.
Why the study?
Cardiac amyloidosis represents a challenging diagnosis in multiple myeloma patients, frequently presenting as refractory heart failure with subtle early features that can delay therapy.
Case Report (n=1)
Global longitudinal strain (GLS) is a crucial non-invasive diagnostic and prognostic marker for detecting and monitoring progressive cardiac amyloidosis in patients with multiple myeloma.
May support GLS monitoring in myeloma-associated amyloidosis; hypothesis-generating, requiring prospective validation before clinical adoption.
Background: Cardiac amyloidosis represents a challenging diagnosis in patients with multiple myeloma, often presenting as refractory heart failure with subtle early manifestations that can delay appropriate treatment. Case: We report a 55-year-old male with a three-year history of multiple myeloma who presented with progressive dyspnea and bilateral lower limb edema. Despite being normotensive and non-diabetic, he exhibited clinical signs of volume overload with elevated jugular venous pressure and bilateral crepitations. Electrocardiography revealed left ventricular hypertrophy with strain pattern, left axis deviation, and left bundle branch block, raising suspicion for infiltrative cardiomyopathy. Transthoracic echocardiography demonstrated moderate concentric left ventricular hypertrophy with reduced ejection fraction (40%) and severe grade III diastolic dysfunction. Global longitudinal strain analysis revealed markedly reduced GLS at -9.7% with characteristic apical sparing pattern, creating the pathognomonic "cherry-on-top" appearance. Despite optimal heart failure management and continued multiple myeloma treatment, six-month follow-up demonstrated dramatic GLS deterioration to -1.9% , indicating progressive cardiac amyloidosis and poor prognosis. Conclusion: Global longitudinal strain serves as both a sensitive diagnostic tool and powerful prognostic marker in cardiac amyloidosis secondary to multiple myeloma, supporting its integration into routine cardiac surveillance protocols for patients with plasma cell disorders to enable earlier diagnosis and better risk stratification.
No takes yet. Share an insight, caveat, or question.
Sridevi et al. (2026) conducted a case report in Cardiac amyloidosis secondary to multiple myeloma (n=1). Global longitudinal strain (GLS) monitoring was evaluated on Change in Global Longitudinal Strain (GLS). Global longitudinal strain identified a characteristic apical sparing pattern and deteriorated from -9.7% to -1.9% over 6 months, demonstrating its diagnostic and prognostic utility in monitoring progressive cardiac amyloidosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: